Conditions: Glaucoma
Keywords: Primary open-angle glaucoma Ocular hypertension Pigment dispersion glaucoma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 9
Healthy volunteers: no

Brief summary:
The purpose of this study was to assess the efficacy and tolerability of changing to AZARGA® from prior COMBIGAN® pharmacotherapy in patients with open-angle glaucoma or ocular hypertension.

Detailed description:

Arms:
arm 1: Brinzolamide/timolol maleate fixed combination, one drop self-administered in study eye(s) twice a day for 8 weeks

Interventions: intervention 1: Brinzolamide/timolol maleate fixed combination
Intervention descriptions: intervention 1: Commercially marketed topical ocular agent for the treatment of open-angle glaucoma (OAG) or ocular hypertension.

Protocol document: